← Back to All Filings

Guardant Health CFO Sells Shares for Tax Withholding on Vested RSUs

Low SignificanceDecember 17, 2025 at 7:32:37 PM EST

Guardant Health, Inc.

$GH4CIK: 0001576280

Subscribe to track GH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Guardant Health CFO Sells Shares for Tax Withholding

Company: Guardant Health, Inc. (GH) Form: 4 | Filed: 2025/12/17 Significance: Low

Insider: Bell Michael Brian Title: Chief Financial Officer | Relationship: Officer

Transaction: • Type: Tax Withholding Sale • Shares: 1,659 • Price: $102.67 • Value: $170,330 • Owned After: 29,665

Key Insight: This is an automatic sale to cover tax liabilities from vesting RSUs, not a discretionary trade. The CFO acquired a net of 1,613 shares from the vesting event.

Market Context: The transaction value represents a negligible fraction (<0.002%) of Guardant Health's $12.26B market capitalization.

Comprehensive Analysis

SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Financial Officer of Guardant Health executed an automatic, non-discretionary sale of shares to cover tax obligations arising from the vesting of Restricted Stock Units (RSUs).
  • Market Impact: The transaction is routine and has a negligible financial impact, representing less than 0.002% of the company's market capitalization. It is not indicative of a change in insider sentiment.

Company Information

FieldValue
CompanyGuardant Health, Inc.
Ticker SymbolGH
CIK0001576280
IndustryMedical Laboratories

Insider Information

FieldValue
NameBell Michael Brian
CIK0001702824
Title/PositionChief Financial Officer
RelationshipOfficer

Transaction Details

This filing reports the vesting of 3,272 Restricted Stock Units (RSUs) and a subsequent automatic sale to cover taxes.

FieldValue
Form Type4
Transaction Date2025-12-15
Transaction CodeF (Tax Withholding Sale)
Security TypeCommon Stock
Shares Involved1,659 (Sold for taxes)
Price Per Share$102.67
Total Value$170,329.53
Shares Owned After29,665
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$170,329.53
% of Market Cap<0.002%
Shares Transacted1,659
% of Shares OutstandingNot Available
Post-Transaction Ownership29,665 shares
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The sale of ~$170k is immaterial for a company with a market capitalization of $12.26 billion.
  • Transaction Significance: The transaction is a 'sell-to-cover' action, which is automated and required to meet tax obligations on equity compensation. It does not reflect a discretionary investment decision by the CFO. The insider's net position increased by 1,613 shares as a result of the overall vesting event.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: Automated tax-related sales are common and do not provide a signal to the market. The transaction size is insignificant relative to the company's market value.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares is too small to impact trading volume.
  • Sentiment Indicator: Neutral. This type of filing is considered routine administrative action for executive compensation.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's footnote explicitly states, "These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units."
Topics:#SECFiling#InsiderTrading#GH#GuardantHealth#Form4#CFO#RSU#StockVesting#MarketAnalysis#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.